Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button


Home > Press > ZyGEM and Commonwealth Biotechnologies Announce Research Collaboration for DNA Extraction Products

- Companies are Joining Forces to Further Evaluate and Apply ZyGEM's Unique DNA Extraction Technology to CBI's DNA Forensic Operations - - Includes Potential Development of New DNA Forensic Analysis Products -

ZyGEM and Commonwealth Biotechnologies Announce Research Collaboration for DNA Extraction Products

SOLANA BEACH, CA, HAMILTON, New Zealand and RICHMOND, VA | Posted on September 4th, 2008

ZyGEM Corp. Ltd. today announced that it has entered into a collaboration with Commonwealth Biotechnologies, Inc. (CBI) (CBTE:
commonwealth biotechnologies com
News, chart, profile, more
Last: 0.850.00-0.59%
12:07pm 09/04/2008
Delayed quote data
Add to portfolio
Create alert
Sponsored by:
CBTE 0.85, 0.00, -0.6%) to further evaluate and use ZyGEM's forensicGEM(TM) DNA extraction technology in CBI's forensic operations. The collaboration will also combine ZyGEM's innovative technologies and CBI's forensic expertise to develop additional products for the forensic DNA market. Terms of the collaboration were not disclosed.
"Our forensicGEM(TM) DNA extraction kits provide important advantages to forensic scientists, and we are delighted to partner in the U.S. with a technically sophisticated, knowledgeable and respected company such as CBI," said Paul Kinnon, CEO of ZyGEM. "We believe that our unique DNA extraction products are easy to implement in a variety of settings and have the potential to generate significant process improvements and efficiencies. We understand that CBI scientists are already achieving success in integrating our newly expanded portfolio of forensic products into their workflows, and we look forward to joining forces to develop additional products for this growing field."
CBI is integrating ZyGEM's forensicGEM(TM) kits into its Fairfax Identity Laboratories DNA reference operations. A leader in the research, development and use of advanced forensic procedures, CBI's Fairfax Identity Laboratories analyze over 50,000 forensic samples each year while also developing enhanced forensic testing procedures.
"We are very pleased with the performance to date of ZyGEM's unique nucleic acid extraction technology and expect that it will continue to provide us with improvements in turnaround, efficiency and cost, especially for our growing volume of CODIS sample processing," said Thomas R. Reynolds, executive vice president of science and technology at CBI. "We also look forward to combining our complementary expertise to develop additional new products for improved DNA forensic processing."
The forensicGEM(TM) family of kits uses a proprietary enzyme to extract DNA from samples using a single closed-tube system. The forensicGEM(TM) approach simplifies laboratory workflow, minimizes error, reduces the risk of contamination and ensures sample integrity while also reducing costs. The kits are easy to automate for high-throughput applications using off-the-shelf robotic systems. They have been specifically formulated for DNA extraction from a range of different crime sample types without the need for further purification. With forensicGEM(TM), researchers can prepare samples up to three times faster than with existing products and at a lower cost.


About ZyGEM Corp. Ltd.
ZyGEM Corporation Limited is a rapidly growing biotechnology company with a range of innovative enzyme-based products and technologies based on the company's exclusive collection of microorganisms from extreme environments. ZyGEM's technology has significant competitive advantages over existing methods and has potential applications in a number of sizeable global markets. ZyGEM currently produces DNA extraction and detection products, molecular biology enzymes and individual enzymes and diagnostics, serving life sciences customers in basic research, forensics, clinical diagnostics and agriculture. ZyGEM has facilities in New Zealand and the U.S.A.

About Commonwealth Biotechnologies, Inc.
CBI offers cutting-edge research and development products and services to the global life sciences industry. CBI now operates through: (1) CBI Services, a discovery phase contract research organization; (2) Fairfax Identity Laboratories, a DNA reference business; (3) Mimotopes Pty Ltd, Melbourne, Australia, a peptide and discovery chemistry business; (4) Exelgen Ltd, Bude, UK, a medicinal and synthetic discovery chemistry business; and (5) Venturepharm (Asia), Shanghai and Beijing, China, a contract research joint venture specializing in drug discovery and development, process scale-up, formulation development, cGMP manufacturing and clinical trial management. CBI companies directly employ over 120 staff in three world-class laboratories and have access to over 2,000 additional staff through CBI's Venturepharm (Asia) joint venture. For more information, visit CBI on the web at .
Forward Looking Statements
No statement made in this press release should be interpreted as an offer to purchase any security. Such an offer can only be made in accordance with the Securities Act of 1933, as amended, and applicable state securities laws. Any statements contained in this release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties as identified in CBI's filings with the Securities and Exchange Commission. Actual results, events or performance may differ materially. Readers are cautioned not to place undo reliance on these forward-looking statements, which speak only as the date hereof. Specifically, CBI cannot guarantee that the collaboration with ZyGEM will produce any revenues or meet the prospects referenced herein. CBI undertakes no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect the events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

For more information, please click here

Paul Kinnon
President and CEO
858 720-8333

Barbara Lindheim
BioCom Partners
212 918-4650

Commonwealth Biotechnologies
Thomas Reynolds
EVP Science & Technology
804 648-3820

Copyright © PR Newswire Association LLC.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Scientists found a natural nanostructure to control the flow of light October 4th, 2015

Horizontal magnetic tunneling in a field-effect device integrated on Silicon October 3rd, 2015

Crystal clear: Thousand-fold fluorescence enhancement in an all-polymer thin film: Griffith University researchers report breakthrough due to novel and multi-layer Colloidal Photonic Crystal structure October 2nd, 2015

Industrial Nanotech, Inc. Announces New Office in Arizona to Service the Company's New Regional and National Home Builders in Arizona and Nevada October 2nd, 2015


Sniffing out cancer with improved 'electronic nose' sensors October 2nd, 2015

Hopes of improved brain implants October 1st, 2015

New Nanomaterials Taking Research to Mexico, Possibly into Space September 29th, 2015

Cristal Therapeutics Starts Clinical Phase I Trial with Nanomedicine CriPec® Docetaxel in Patients with Solid Tumours September 29th, 2015


Scientists found a natural nanostructure to control the flow of light October 4th, 2015

Industrial Nanotech, Inc. Announces New Office in Arizona to Service the Company's New Regional and National Home Builders in Arizona and Nevada October 2nd, 2015

Production of High Temperature Ceramics with Modified Properties in Iran October 2nd, 2015

ISO Approves 2 Int'l Nanotechnology-Related Standards Proposed by Iran October 2nd, 2015

Alliances/Trade associations/Partnerships/Distributorships

SUNY Poly Announces Joint Development Agreement with INFICON to Establish Cutting Edge R&D Partnership Supporting New York State’s Rapidly Expanding Nanoelectronics Industry September 23rd, 2015

Pushing the limits of lensless imaging: At the Frontiers in Optics conference researchers will describe a custom-built ultrafast laser that could help image everything from semiconductor chips to cells in real time September 21st, 2015

Nanotech expertise earns Virginia Tech a spot in National Science Foundation network: New center's focus will be on earth, environmental nanotechnology September 16th, 2015

Graphene Enhanced ARALDITE Resin Composite Materials September 14th, 2015

The latest news from around the world, FREE

  Premium Products
Only the news you want to read!
 Learn More
University Technology Transfer & Patents
 Learn More
Full-service, expert consulting
 Learn More

Nanotechnology Now Featured Books


The Hunger Project

Car Brands
Buy website traffic